IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner

Autor: Jinglin Xia, Peixin Huang, Qian-Wen Rao, Donghe Li, Jialei Sun, Tingting Fang, Zhiying Zhao, Feng Qi, Biwei Yang, Feifei Yuan, Mengzhou Guo
Rok vydání: 2019
Předmět:
Zdroj: Biochemical and biophysical research communications. 523(3)
ISSN: 1090-2104
Popis: Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide that responds poorly to existing therapies. The Casein kinase 1 (CK1) isoforms CK1δ and CK1e are reported to be highly expressed in several tumor types, and both genetic and pharmacological inhibition of CK1δ/e activity has deleterious effects on tumor cell growth. IC261, an CK1δ/e selectively inhibitor, shows anti-tumor effect against pancreatic tumor and glioblastoma, but its role in HCC remains poorly characterized. In our research, IC261 displayed time- and dose-dependent inhibition of HCC cell proliferation, and induced G2/M arrest and cell apoptosis in vitro. However, the anti-tumor effects of IC261 was independent of CK1δ/e. Additionally, IC261 was verified to induce centrosome fragmentation during mitosis independent of CK1δ status, and intraperitoneal injection of IC261 to HCCLM3 xenograft models inhibited tumor growth. Taken together, our data indicated that IC261 has therapeutic potential for HCC.
Databáze: OpenAIRE